Work

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

Year: 2002

Type: article

Study design: Clinical Trial

Source: Seminars in Radiation Oncology

DOI: 10.1053/srao.2002.31375

Authors: Matthew Arquette, Todd Wasserman, Ramaswamy Govindan, David Garfield, Neil Senzer, Heidi Gillenwater, Mark Socinski

Institutions: University of North Carolina at Chapel Hill, Washington University in St. Louis

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2006511347

FWCI: 0.887

Cites: 7

Cited by: 13

Related to: 10